Sequent Anti Biotics Private Limited

Develops, manufactures, and distributes pharmaceutical drugs and medicines.

2010 | Bangaluru, Karnataka (India) | Inactive
Last Updated: February 13, 2025

Sequent Anti Biotics Profile

Key Indicators

  • Authorised Capital ₹ 0.70 M
  • Paid Up Capital ₹ 0.70 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2018

About Sequent Anti Biotics

Sequent Anti Biotics Private Limited (SABPL) is Strike Off company established on 04 May 2010 with its office registered at Bangaluru, Karnataka, India and has been running since 14 Year, 9 Months with a paid up capital of 0.70 M. According to MCA records, 2 Directors are linked to this company as of 13 Feb 2025.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    sequent.in

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230KA2010PTC053487

  • Company No.

    053487

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 May 2010

  • Date of AGM

    25 Sep 2018

  • Date of Balance Sheet

    31 Mar 2018

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Life Sciences

Who are the key members and board of directors at Sequent Anti Biotics?

Board Members (2)

NameDesignationAppointment DateStatus
Sharat Narasapur Country flag representing In Director 10-May-2017Current
Tushar Mistry Country flag representing In Director 10-May-2017Current

Financial Performance of Sequent Anti Biotics.

Sequent Anti Biotics Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Sequent Anti Biotics?

In 2017, Sequent Anti Biotics had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Sequent Anti Biotics?

Unlock and access historical data on people associated with Sequent Anti Biotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sequent Anti Biotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequent Anti Biotics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sequent Anti Biotics

Recent activity within the organization

  • Annual General Meeting

    Sequent Anti Biotics Private Limited last Annual general meeting of members was held on 25 Sep 2018 as per latest MCA records.

    25 Sep 2018

  • Balance Sheet

    Sequent Anti Biotics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Bangalore.

    31 Mar 2018

  • Director Appointment

    Sharat Pandu Rang Narasapur was appointed as a Director was appointed as a Director on 10 May 2017 & has been associated with this company since 7 years 9 months .

    10 May 2017

  • Director Appointment

    Tushar Pravinchandra Mistry was appointed as a Director was appointed as a Director on 10 May 2017 & has been associated with this company since 7 years 9 months .

    10 May 2017

  • Company Incorporation

    Sequent Anti Biotics Private Limited was registered on 04 May 2010 with Roc Bangalore & aged 14 years 9 months as per MCA records.

    04 May 2010

Recent News, Updates & Announcement

Frequently asked questions

  • Sequent Anti Biotics Private Limited was incorporated on 04 May 2010.

  • The authorized share capital of Sequent Anti Biotics Private Limited is ₹ 0.70 M and paid-up capital is ₹ 0.70 M.

  • Currently 2 directors are associated with Sequent Anti Biotics Private Limited.

    • Sharat Pandu Rang Narasapur
    • Tushar Pravinchandra Mistry
  • As per Ministry of Corporate Affairs (Mca), the registered address of Sequent Anti Biotics Private Limited is Star Ii Opp. Iim Bilekahalli Bannerghatta Road, India, Bangalore, Karnataka, 560076.

  • The corporate identification number (CIN) of Sequent Anti Biotics Private Limited is U24230KA2010PTC053487 and the company number is 053487 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Sequent Anti Biotics Private Limited is https://www.sequent.in

  • The most recent Balance Sheet for Sequent Anti Biotics Private Limited was filed with the ROC on 31 Mar 2018.

People also Viewed

Similar Companies Based on Biotechnology